How food and age affect study drug LY03017
Part of Brain & nervous system, Mental health clinical trials.
This trial studies how a new investigational drug (LY03017) moves through the body in younger adults and older adults, and whether food changes that. It will help researchers understand how to dose the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old, OR you are 65 years or older.
- You weigh at least 110 pounds (men) or 99 pounds (women).
- Your body mass index (BMI) is between 18.5 and 28.
- You are generally healthy, or if over 65, you have well-controlled conditions like high blood pressure or diabetes.
- You are willing to follow diet and lifestyle rules during the study.
- You are not pregnant, breastfeeding, or planning to donate sperm or eggs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new investigational drug called LY03017 to see if it's safe and how the body processes it. It is for healthy volunteers between 18 and 45 years old.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial studies a new drug called FB418 to see if it's safe and how the body handles it. It first tests single doses in younger healthy men, then multiple doses, and also includes an optional group for healthy older adults.
This trial tests a new medicine called LY03021 in healthy volunteers to see how safe it is, how the body processes it, and if food changes its effects. It's for people who are generally healthy and not taking other medications.
This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.
This study tests an experimental drug called LY3439539 in people with early-stage Alzheimer's disease. The drug is designed to target protein changes in the brain that may slow memory loss and cognitive decline.
Hear when a new Alzheimer's Disease Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.